Home > Insider Trading > Filing (0001209191-19-018606)

Filing Details

Accession Number:: 0001209191-19-018606
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-11 19:11:55
Reporting Period:: 2019-03-07

Accepted Time:: 2019-03-11 19:11:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1227636	Neuronetics Inc.	STIM	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408320	Peter Donato	C/O Neuronetics, Inc. 3222 Phoenixville Pike Malvern PA 19355	Vice President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-03-07	18,061	$3.19	18,061	No	4	M	Direct
Common Stock	Disposition	2019-03-07	18,061	$16.21	0	No	4	S	Direct
Common Stock	Acquisiton	2019-03-08	8,177	$3.19	8,177	No	4	M	Direct
Common Stock	Disposition	2019-03-08	8,177	$16.01	0	No	4	S	Direct
Common Stock	Acquisiton	2019-03-08	14,007	$0.00	14,007	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-03-07	18,061	$0.00	18,061	$3.19
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-03-08	8,177	$0.00	8,177	$3.19
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2019-03-08	24,652	$0.00	24,652	$16.42

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
86,890	2027-04-11	No	4	M	Direct
78,713	2027-04-11	No	4	M	Direct
24,652	2029-03-08	No	4	A	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.085 inclusive.
Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.